In a neuroblastoma model, MIF inhibits T cell activation in vivo [22,41], and MIF inhibition has been shown to promote conversion of melanoma patient-derived MDSCs into a more DC-like phenotype in vitro [21]. Here, MIF is linked to neuroblastoma.